Want to join the conversation?
At year-end 2015, $MAR's available borrowing capacity amounted to $1,158MM. The ratio of current assets to current liabilities for the company was 0.4 to 1.0 at year-end 2015 compared to 0.5 to 1.0 for the same period a year ago. Debt rose by $336MM for the year to $4,107MM at year-end 2015, reflecting $790MM in Series O and P Notes issuances.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.